Genetic polymorphisms −137 (G > C) (rs187238) and −607 (C > A) (rs1946518) and serum level of interleukin 18 in Fars ethnic groups with metabolic syndrome in Northern Iran

References

• Alberti, K.G., et al., 2009. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 120 (16), 1640–1645.
   PubMed Web of Science ®Google Scholar
• Arimitsu, J., et al., 2006. IL-18 gene polymorphisms affect IL-18 production capability by monocytes. Biochemical and biophysical research communications, 342 (4), 1413–1416.
   PubMed Web of Science ®Google Scholar
• Aso Y., et al., 2003. Relationships of plasma IL-18 concentrations to hyperhomocysteinemia and carotid intimal-media wall thickness in patients with type 2 diabetes. Diabetes care, 26 (9), 2622–2627.
   PubMed Web of Science ®Google Scholar
• Biondi-Zoccai, G.G., et al., 2003. Atherothrombosis, inflammation, and diabetes. Journal of the American college of cardiology, 41 (7), 1071e7.
   Web of Science ®Google Scholar
• Blankenberg, S., et al., 2002. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation, 106 (1), 24–30.
   PubMed Web of Science ®Google Scholar
• Blankenberg, S., et al., 2003. Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation, 108 (20), 2453–2459.
   PubMed Web of Science ®Google Scholar
• Cardoso, S.M., et al., 2004. Patient interleukin-18 GCG haplotype associates with improved survival and decreased transplantrelated mortality after unrelated-donor bone marrow transplantation. British journal of haematology, 126 (5), 704–710.
   PubMed Web of Science ®Google Scholar
• Chang, M., et al., 1995. Use of omeprazole as a probe drug for CYP2C19 phenotype in Swedish Caucasians: comparison with S-mephenytoin hydroxylation phenotype and CYP2C19 genotype. Pharmacogenetics, 5, 358–363.
   PubMedGoogle Scholar
• Cornier, M.A., et al., 2008. The metabolic syndrome. Endocrine reviews, 29 (7), 777–822.
   PubMed Web of Science ®Google Scholar
• Crowther, N.J., et al., 2006. The effect of abdominal obesity on insulin sensitivity and serum lipid and cytokine concentrations in African women. Clinical endocrinology, 64 (5), 535–554.
   PubMed Web of Science ®Google Scholar
• Dinarello, C., 1999. IL-18: a TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. The journal of allergy and clinical immunology, 103 (1 Pt 1), 11–24.
   PubMed Web of Science ®Google Scholar
• Escobar-Morreale, H.F., et al., 2004. Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity. The journal of clinical endocrinology & metabolism, 89 (2), 806–811.
   PubMed Web of Science ®Google Scholar
• Espinola-Klein, C., et al., for the AtheroGene Investigators, 2008. Impact of inflammatory markers on cardiovascular mortality in patients with metabolic syndrome. European journal of cardiovascular prevention & rehabilitation, 15 (3), 278–284.
   PubMedGoogle Scholar
• Esposito, K., et al., 2002. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation, 106 (16), 2067–2072.
   PubMed Web of Science ®Google Scholar
• Esposito, K., et al., 2002. Weight loss reduces interleukin-18 levels in obese women. The journal of clinical endocrinology & metabolism, 87 (8), 3864–3866.
   PubMed Web of Science ®Google Scholar
• Esposito K., et al., 2003. Cytokine milieu tends toward inflammation in type 2 diabetes. Diabetes Care, 26:1647.
   PubMed Web of Science ®Google Scholar
• Everett, B.M., et al., 2009. Interleukin-18 and the risk of future cardiovascular disease among initially healthy women. Atherosclerosis, 202 (1), 282–288.
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection and Evaluation of High Blood Cholesterol in Adults. 2001. Executive summary of the third report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Jama, 285, 2486–2497.
   PubMed Web of Science ®Google Scholar
• Fatima, S.S., et al., 2017. Interleukin-18 polymorphism as an inflammatory index in metabolic syndrome: a preliminary study. World journal of diabetes, 8 (6), 304–310.
   PubMed Web of Science ®Google Scholar
• Giedraitis, V., et al., 2001. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. Journal of neuroimmunology, 112 (1–2), 146–152.
   PubMed Web of Science ®Google Scholar
• Gracie, J.A., et al., 2005. Disease association of two distinct interleukin-18 promoter polymorphisms in Caucasian rheumatoid arthritis patients. Genes and immunity, 6 (3), 211–216.
   PubMed Web of Science ®Google Scholar
• Grundy, S.M., 2008. Metabolic syndrome pandemic. Arteriosclerosis, thrombosis, and vascular biology, 28 (4), 629–636.
   PubMed Web of Science ®Google Scholar
• Hart, R., Hickey, M., and Franks, S., 2004. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome. Best practice & research clinical obstetrics & gynaecology, 18 (5), 671–683.
   PubMed Web of Science ®Google Scholar
• He, M., et al., 2010. GenomeWide Association Study identifies variants at the IL18-BCO2 locus associated with interleukin-18 levels. Arteriosclerosis, thrombosis, and vascular biology, 30 (4), 885–890.
   PubMed Web of Science ®Google Scholar
• Hivert, M.F., et al., 2009. Circulating IL18 and the risk of type 2 diabetes in women. Diabetologia, 52 (10), 2101–2108.
   PubMed Web of Science ®Google Scholar
• Hung, J., et al., 2005. Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance. Arteriosclerosis, thrombosis, and vascular biology, 25 (6), 1268–1273.
   PubMed Web of Science ®Google Scholar
• Hung, J., et al., 2008. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity. International journal of obesity, 32 (5), 772–779.
   Web of Science ®Google Scholar
• Ide, A., et al., 2004. Association between IL-18 gene promoter polymorphisms and CTLA-4 gene 49A/G polymorphism in Japanese patients with type 1 diabetes. Journal of autoimmunity, 22 (1), 73–78.
   PubMed Web of Science ®Google Scholar
• Khripko, O.P., et al. 2008. Association of single nucleotide polymorphisms in the IL18gene with production of IL18 protein by mononuclear cells from healthy donors. Mediators Inflamm. 2008, 309721.
   PubMed Web of Science ®Google Scholar
• Kim, J., et al., 2012. Association of IL-18 genotype with impaired glucose regulation in Korean women with polycystic ovary syndrome. European journal of obstetrics, gynecology, and reproductive biology, 161 (1), 51–55.
   PubMed Web of Science ®Google Scholar
• Kretowski, A., et al., 2002. Interleukin-18 promoter polymorphisms in type 1 diabetes. Diabetes, 51 (11), 3347–3349.
   PubMed Web of Science ®Google Scholar
• Lakka, H.M., et al., 2002. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. Jama, 288 (21), 2709–2716.
   PubMed Web of Science ®Google Scholar
• Liang, X.H., et al., 2005. Reduced transcriptional activity in individuals with IL-18 gene variants detected from functional but not association study. Biochemical and biophysical research communications, 338 (2), 736–741.
   PubMed Web of Science ®Google Scholar
• Ness, R.B., et al., 2004. Differential distribution of allelic variants in cytokine genes among African Americans and White Americans. American journal of epidemiology, 160 (11), 1033–1038.
   PubMed Web of Science ®Google Scholar
• Novota, P., et al., 2005. Interleukin IL-18 gene promoter polymorphisms in adult patients with type 1 diabetes mellitus and latent autoimmune diabetes in adults. Immunology letters, 96 (2), 247–251.
   PubMed Web of Science ®Google Scholar
• Pickup, J.C., 2004. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes care, 27 (3), 813.
   PubMed Web of Science ®Google Scholar
• Pradhan, A.D. and Ridker, P.M., 2002. Do atherosclerosis and type 2 diabetes share a common inflammatory basis? European heart journal, 23 (11), 831–834.
   PubMed Web of Science ®Google Scholar
• Presta, I., et al., 2009. IL-18 gene polymorphism and metabolic syndrome. Nutrition, metabolism, and cardiovascular diseases, 19 (2), e5–e6.
   PubMed Web of Science ®Google Scholar
• Rabkin, S.W., 2009. The role of interleukin 18 in the pathogenesis of hypertension-induced vascular disease. Nature clinical practice. Cardiovascular medicine, 6 (3), 192–199.
   PubMedGoogle Scholar
• Riley, J. and Jungheim, E., 2016. Is there a role for diet in ameliorating the reproductive sequelae associated with chronic lowgrade inflammation in polycystic ovary syndrome and obesity?. Fertility and sterility, 106 (3), 520–527.
   PubMed Web of Science ®Google Scholar
• Rueda, B., et al., 2005. Interleukin-18-promoter polymorphisms are not relevant in rheumatoid arthritis. Tissue antigens, 65 (6), 544–548.
   PubMedGoogle Scholar
• Satoh, K., 1978. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clinica chimica acta, 90 (1), 37–43.
   PubMed Web of Science ®Google Scholar
• Shorakae, S., et al., 2015. The emerging role of chronic low-grade inflammation in the pathophysiology of polycystic ovary syndrome. Seminars in reproductive medicine, 33 (4), 257–269.
   PubMed Web of Science ®Google Scholar
• Sivalingam, S.P., et al., 2003. Single-nucleotide polymorphisms of the interleukin-18 gene promoter region in rheumatoid arthritis patients: protective effect of AA genotype. Tissue antigens, 62 (6), 498–504.
   PubMedGoogle Scholar
• Szeszko, J.S., et al., 2006. Analysis of polymorphisms of the interleukin-18 gene in type 1 diabetes and Hardy-Weinberg equilibrium testing. Diabetes, 55 (2), 559–562.
   PubMed Web of Science ®Google Scholar
• Takada, T., et al., 2002. Association of single nucleotide polymorphisms in the IL-18 gene with sarcoidosis in a Japanese population. Tissue antigens, 60 (1), 36–42.
   PubMedGoogle Scholar
• Takagawa, T., et al., 2005. Association between IL-18 gene promoter polymorphisms and inflammatory bowel disease in a Japanese population. Inflammatory bowel diseases, 11, 1038–1043.
   PubMed Web of Science ®Google Scholar
• Tiret, L., et al., 2005. Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease. Circulation, 112 (5), 643–650.
   PubMed Web of Science ®Google Scholar
• Troseid, M., et al., 2009. Interleukin-18 is a strong predictor of cardiovascular events in elderly men with the metabolic syndrome: synergistic effect of inflammation and hyperglycemia. Diabetes care, 32 (3), 486–492.
   PubMed Web of Science ®Google Scholar
• Troseid, M., et al., 2010. Arterial stiffness is independently associated with interleukin-18 and components of the metabolic syndrome. Atherosclerosis, 209 (2), 337–339.
   PubMed Web of Science ®Google Scholar
• Troseid, M., Seljeflot, I., and Arnesen, H., 2010. The role of interleukin-18 in the metabolic syndrome. Cardiovascular diabetology, 9, 11.
   PubMed Web of Science ®Google Scholar
• Tsiavou, A., et al., 2005. Correlation between intracellular interferon-gamma (IFN-gamma) production by CD4+ and CD8+ lymphocytes and IFN-gamma gene polymorphism in patients with type 2 diabetes mellitus and latent autoimmune diabetes of adults (LADA). Cytokine, 31 (2), 135–141.
   PubMed Web of Science ®Google Scholar
• Wang, Q., et al., 2018. Association of IL-18 polymorphisms with risk of polycystic ovary syndrome in a Han population of China. Biomedical research, 29 (1), 108–112.
   Google Scholar
• Wei, Y.-S., et al., 2007. Interleukin-18 gene promoter polymorphisms and the risk of esophageal squamous cell carcinoma. Acta oncologica, 46 (8), 1090–1096.
   PubMed Web of Science ®Google Scholar
• Yang, Y., Qiao, J., and Li, M., 2010. Association of polymorphisms of interleukin-18 gene promoter region with polycystic ovary syndrome in Chinese population. Reproductive biology and endocrinology, 8, 125–131.
   PubMed Web of Science ®Google Scholar